Oral Health » Oncology Oral Care

ID #1005

Oncology Oral Care


Oral complications occur in virtually all patients receiving radiation for head and neck malignancies, in approximately 80% of hematopoietic (blood-forming) stem cell transplant recipients , and in nearly 40 % of patients receiving chemotherapy. Some complications occur only during treatment; others such as Xerostomia , may persist for years. Unfortunately, patients with cancer do not always receive needed oral care until serious complications develop.

Oral complications of cancer treatment arise in various forms and degrees of severity, depending on the individual and the cancer treatment.  Chemotherapy often impairs the function of bone marrow, suppressing the formation of white blood cells, red blood cells, and platelets (myelsosuppression). Some cancer treatments are described as stomatotoxic because they have toxic effects on the oral tissues.. The following are common to both chemotherapy and radiation therapy:

Oral Mucositis:  inflammation and ulceration of the mucous membranes; can increase risk of pain, oral and systemic infection, and nutritional compromise

Infection: viral, bacterial, and fungal (Oral Thrush); results from dry mouth (Xerostomia) and damage to the mucosa from chemotherapy and radiation

Dry Mouth (Xerostomia)/salivary gland dysfunction: dryness of the mouth due to thickened, reduced, or absent salivary flow; increases risk of infection and compromises speaking, chewing, and swallowing.  Some medications, other than chemotherapy, can also cause salivary gland dysfunction. Persistant dry mouth increases the risk of dental caries.

Functional disabilities: impaired ability to eat, taste, swallow, and speak because of Mucositis, Xerostomia, trismus, and infection

Taste alterations: changes in taste perception of foods, ranging from unpleasant to tasteless

Nutritional compromise: poor nutrition from eating difficulties caused by Mucositis, dry mouth, dysphasia, and loss of taste.

Abnormal dental development: altered tooth development and craniofacial growth. 


MedActive Oral Relief Protocol* for Oncology


To learn more about MedActive's doctor recommended protocol, visit Oncology Oral Care .


Patient-Friendly™ MedActive Oral Relief Products Rely on Compliance


Sustaining patient commitment to a daily oral protocol-compliance-is a critically important medical objective. All MedActive Oral Relief Products are carefully formulated to deliver a consistently pleasant taste and mouthfeel experience to encourage protocol compliance. In addition to containing saliva enhancing, cleansing, lubricating, moisturizing, and protective ingredients, Patient-Friendly™ MedActive products feature flavors and mouthfeel elements that form the cornerstone to achieving high patient compliance.


*Important Patient Information


MedActive strongly advises all users with oral health problems to consult a doctor, who will be trained in observation and interpretation of symptoms and will be able to provide a proper diagnosis based on a knowledge and understanding of all aspects of your condition and your medical history.  For further information visit Terms & Conditions .


© 2009 MEDACTIVE ORAL PHARMACEUTICALS, LLC


Tags: -

Related entries:

Last update: 2009-11-18 13:22
Author: Dr. Jeffery Hameroff
Revision: 1.125

Digg it! Print this record Send to a friend Show this as PDF file